BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240306
DTEND;VALUE=DATE:20240311
DTSTAMP:20260415T155217
CREATED:20231222T142749Z
LAST-MODIFIED:20231222T143108Z
UID:3326-1709683200-1710115199@scge.mcw.edu
SUMMARY:The Allied Genetics Conference 2024
DESCRIPTION:The Allied Genetics Conference (TAGC) is a unique conference organized by the Genetics Society of America that offers innovative sessions that get to the heart of our shared research interests. The diverse and interdisciplinary scope of TAGC 2024 allows researchers to discover answers and explore new directions in today’s genetics and genomics research. \nFind more information at: https://genetics-gsa.org/tagc-2024/
URL:https://scge.mcw.edu/events/tagc-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2023/12/TAGC24-Website-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240328
DTSTAMP:20260415T155217
CREATED:20240104T154602Z
LAST-MODIFIED:20240104T154639Z
UID:3512-1711324800-1711583999@scge.mcw.edu
SUMMARY:Genomics of Rare Disease
DESCRIPTION:The 18th conference on rare disease combines recent research on genetic mechanisms involved in disease\, with advances in approaches for clinical care. This year’s conference will include discussions on the use of a ‘pangenome’ to improve diagnostic yield\, the role of common variants in rare disease\, and new developments in prenatal and neonatal genomic screening. This highly-interactive meeting fosters knowledge exchange among clinicians\, clinical scientists\, researchers and bioinformaticians working on rare diseases. \nFind more information at: https://coursesandconferences.wellcomeconnectingscience.org/event/genomics-of-rare-disease-20240325/
URL:https://scge.mcw.edu/events/genomics-of-rare-disease/
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2024/01/Wellcome_Rare-disease.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240328
DTSTAMP:20260415T155217
CREATED:20231220T170622Z
LAST-MODIFIED:20231220T170622Z
UID:3275-1711411200-1711583999@scge.mcw.edu
SUMMARY:Pharma USA 2024
DESCRIPTION:Join pioneers from Commercial\, Marketing\, Medical Affairs\, RWE\, Market Access\, Patient Engagement\, and key stakeholders\, will come together to deliver value to overcome the challenges that threaten the future viability of innovation. \nFind more information at: https://events.reutersevents.com/pharma/pharma-usa
URL:https://scge.mcw.edu/events/pharma-usa-2024/
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2023/12/Pharma-USA-2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240330
DTSTAMP:20260415T155217
CREATED:20231220T171147Z
LAST-MODIFIED:20231220T171147Z
UID:3278-1711411200-1711756799@scge.mcw.edu
SUMMARY:Gene Therapy for Rare Disorders
DESCRIPTION:Bringing together key figures from industry\, regulatory bodies\, patient non-profits\, payers\, and key service providers\, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. \nFind more information at: https://genetherapy-conference.com/
URL:https://scge.mcw.edu/events/gene-therapy-for-rare-disorders/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2023/12/Gene-Therapy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240416
DTEND;VALUE=DATE:20240419
DTSTAMP:20260415T155217
CREATED:20240329T153741Z
LAST-MODIFIED:20240329T153741Z
UID:4167-1713225600-1713484799@scge.mcw.edu
SUMMARY:Gene Therapy for Muscular Disorders
DESCRIPTION:The 4th Gene Therapy for Muscular Disorders Summit in April will focus on gene therapies for muscular disorders to tackle the most pressing challenges and together\, seek solutions to realize these novel therapeutic potentials for patients in need. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLearn more at https://genetherapy-muscular.com/
URL:https://scge.mcw.edu/events/gene-therapy-for-muscular-disorders/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/03/Gene-therapy-event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240422
DTEND;VALUE=DATE:20240425
DTSTAMP:20260415T155217
CREATED:20240104T155413Z
LAST-MODIFIED:20240325T150837Z
UID:3517-1713744000-1714003199@scge.mcw.edu
SUMMARY:CRISPR and Beyond: Perturbations at Scale to Understand Genomes
DESCRIPTION:The rapid development of CRISPR/Cas-based technologies makes it possible to modulate genomes with relative ease. These tools can help us understand how genetic variation influences phenotype and thereby answer long-standing questions in biology that impact human health\, laying the foundations for precision medicine for heritable diseases and cancer treatment. \nThe 5th CRISPR and Beyond conference provides a forum for biomedical researchers from academia and industry working on high throughput screening\, genome engineering\, and variant effect interpretation to discuss perturbations at scale to understand genomes. \nThis year’s meeting will highlight recent advances enabled by emerging technologies and models\, including computational approaches and designing DNA for function. Discussions will focus on the recent discoveries in precision genome editing\, coding and non-coding variation and genetic interactions. A panel discussion will probe how generative modelling and other applications of machine learning are shaping the present and future of the field\, and impacting experimentation. \nFind more information at https://coursesandconferences.wellcomeconnectingscience.org/event/crispr-and-beyond-perturbations-at-scale-to-understand-genomes-20240422/
URL:https://scge.mcw.edu/events/crispr-and-beyond-perturbations-at-scale-to-understand-genomes/
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2024/01/Wellcome_CRISPR.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240423
DTEND;VALUE=DATE:20240426
DTSTAMP:20260415T155217
CREATED:20231220T171921Z
LAST-MODIFIED:20231220T171921Z
UID:3281-1713830400-1714089599@scge.mcw.edu
SUMMARY:The CRISPR MEDiCiNE Conference
DESCRIPTION:Meet the European CRISPR Medicine and Genomic Medicine community to discuss tools\, delivery\, safety\, functional genomics\, standards and regulations\, and more. \nFind more information: https://crisprmedicinenews.com/crisprmed24/
URL:https://scge.mcw.edu/events/the-crispr-medicine-conference/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2023/12/CRISPRmed24.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240429
DTEND;VALUE=DATE:20240502
DTSTAMP:20260415T155217
CREATED:20240102T191210Z
LAST-MODIFIED:20240102T191235Z
UID:3424-1714348800-1714607999@scge.mcw.edu
SUMMARY:Rare Drug Development Symposium
DESCRIPTION:The RARE Drug Development Symposium\, hosted by Global Genes and the Orphan Disease Center of the University of Pennsylvania\, equips advocates with the knowledge\, skills and connections they need to advance therapy development for their communities. \nFind more information at: https://www.globalgenes.org/event/rare-disease-drug-development/ \n 
URL:https://scge.mcw.edu/events/rare-drug-development-symposium/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/RDDS-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240507
DTEND;VALUE=DATE:20240512
DTSTAMP:20260415T155217
CREATED:20231220T175441Z
LAST-MODIFIED:20241112T153259Z
UID:3284-1715040000-1715471999@scge.mcw.edu
SUMMARY:ASGCT Annual Meeting
DESCRIPTION:The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy to learn from the latest scientific research\, stay up to date on new technologies\, and make career-advancing connections with peers. \nLearn more at https://annualmeeting.asgct.org/ \nWant to see the SCGE’s involvement in ASGCT 2024? Click here.
URL:https://scge.mcw.edu/events/asgct-annual-meeting/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2023/12/ASGCT-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240513T090000
DTEND;TZID=America/Chicago:20240513T150000
DTSTAMP:20260415T155217
CREATED:20240301T144525Z
LAST-MODIFIED:20240301T144600Z
UID:4020-1715590800-1715612400@scge.mcw.edu
SUMMARY:Natural History Studies and Registries in the Development of Rare Disease Treatments
DESCRIPTION:This in-person and virtual public workshop will bring together rare disease patient advocates\, academic researchers\, regulated industry\, and other key stakeholders to discuss considerations for the use of natural history study and registry data in rare disease drug development programs. \nFind more information at https://reaganudall.org/news-and-events/events/natural-history-studies-and-registries-development-rare-disease-treatments
URL:https://scge.mcw.edu/events/natural-history-studies-and-registries-in-the-development-of-rare-disease-treatments/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/03/Screenshot-2024-03-01-084335.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240528
DTEND;VALUE=DATE:20240602
DTSTAMP:20260415T155217
CREATED:20240125T171459Z
LAST-MODIFIED:20240125T171527Z
UID:3906-1716854400-1717286399@scge.mcw.edu
SUMMARY:International Society for Cell & Gene Therapy
DESCRIPTION:Address obstacles at each stage of translation and progress the future of cell and gene therapies to bring scientific innovation to therapeutic reality for patients worldwide. \nVancouver\, Canada \nLearn more at https://www.isctglobal.org/isct2024/home
URL:https://scge.mcw.edu/events/international-society-for-cell-gene-therapy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-111426.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240529
DTEND;VALUE=DATE:20240601
DTSTAMP:20260415T155217
CREATED:20240125T171834Z
LAST-MODIFIED:20240125T171834Z
UID:3910-1716940800-1717199999@scge.mcw.edu
SUMMARY:Gene Therapy Patient Engagaement
DESCRIPTION:Join 80+ patient advocacy and engagement professionals at gene therapy companies and patient advocacy groups to gain actionable insights that you can immediately implement into your own gene therapy programs\, and come together with the community to develop solutions to the challenges that are unique to the gene therapy space. \nBoston\, MA \nhttps://genetherapy-patient-engagement.com/
URL:https://scge.mcw.edu/events/gene-therapy-patient-engagaement/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-111803.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240529
DTEND;VALUE=DATE:20240531
DTSTAMP:20260415T155217
CREATED:20240501T134532Z
LAST-MODIFIED:20240501T134532Z
UID:4236-1716940800-1717113599@scge.mcw.edu
SUMMARY:2024 Regulatory Education for Industry
DESCRIPTION:Learn directly from the FDA’s regulatory experts in medical product centers: drugs\, devices\, and biologics. This course is designed to provide participants with a strong\, basic foundation in the FDA’s regulatory requirements\, and also create awareness of current activities. Attend virtually or in-person. \n\nREdI Annual Conference 2024
URL:https://scge.mcw.edu/events/2024-regulatory-education-for-industry/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/05/Screenshot-2024-05-01-084419.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240605T100000
DTEND;TZID=America/Chicago:20240605T143000
DTSTAMP:20260415T155217
CREATED:20240415T153357Z
LAST-MODIFIED:20240415T153357Z
UID:4206-1717581600-1717597800@scge.mcw.edu
SUMMARY:The State of CRISPR and Gene Editing
DESCRIPTION:In The State of CRISPR and Gene Editing virtual summit\, GEN proudly gathers a tantalizing line-up of luminaries from academia and industry to discuss the latest research developments\, innovations\, and advanced technologies that are expanding the CRISPR toolbox\, delivering new therapies to patients and safeguarding our food supply. The webinar is virtual and free to attend. SCGE Researcher David Liu will be giving the opening keynote.\n\nLearn more at https://webinars.liebertpub.com/e/the-state-of-crispr-and-gene-editing-2024
URL:https://scge.mcw.edu/events/the-state-of-crispr-and-gene-editing/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/04/Screenshot-2024-04-15-103326.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240614
DTSTAMP:20260415T155217
CREATED:20240125T172226Z
LAST-MODIFIED:20240125T172226Z
UID:3913-1718064000-1718323199@scge.mcw.edu
SUMMARY:Cell and Gene Therapy Products Symposium
DESCRIPTION:The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing\, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products. \nRockville\, MD \nhttps://www.casss.org/cell-gene-therapy-products
URL:https://scge.mcw.edu/events/cell-and-gene-therapy-products-symposium/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112158.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240612
DTEND;VALUE=DATE:20240615
DTSTAMP:20260415T155217
CREATED:20240329T154054Z
LAST-MODIFIED:20240329T154054Z
UID:4170-1718150400-1718409599@scge.mcw.edu
SUMMARY:Next Generation Gene Therapy Vectors
DESCRIPTION:This event will focus on finding and optimizing novel vectors to increase specificity\, target new cell types\, expand packaging capacities\, and reduce toxicity risks to create safer\, cost-effective and efficacious gene therapies. \nLearn more at https://next-gen-genetherapy-vectors.com/
URL:https://scge.mcw.edu/events/next-generation-gene-therapy-vectors/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/03/gene-therapy-event-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240621
DTSTAMP:20260415T155217
CREATED:20240424T202320Z
LAST-MODIFIED:20240424T202320Z
UID:4216-1718496000-1718927999@scge.mcw.edu
SUMMARY:Genome Engineering: Research and Applications
DESCRIPTION:The conference seeks to present the latest research findings in these fields and support early-career investigators\, women\, and other historically-excluded groups in the field of genome editing. Through collaboration and networking at this meeting\, it can accelerate the translation of fundamental advances into viable genome editing technologies. The conference is being held in Rome\, Italy. \nSCGE researcher Shengdar Tsai is one of the conference organizers\, and SCGE researcher David Liu is the keynote speaker. \nLearn more at https://events.faseb.org/event/genome-engineering-research-applications/summary \n 
URL:https://scge.mcw.edu/events/genome-engineering-research-and-applications/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/04/Screenshot-2024-04-24-152220.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240626
DTEND;VALUE=DATE:20240629
DTSTAMP:20260415T155217
CREATED:20231220T180311Z
LAST-MODIFIED:20231220T180311Z
UID:3287-1719360000-1719619199@scge.mcw.edu
SUMMARY:RNA Therapeutics
DESCRIPTION:Learn more about RNA Therapeutics from concept to clinic from leaders across the field\, including SCGE PI’s Jennifer Doudna\, Kiran Musunuru\, and Sonia Vallabh. \nhttps://www.umassmed.edu/RNATx/
URL:https://scge.mcw.edu/events/rna-therapeutics/
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2023/12/RNA-Therapeutics-24.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240708
DTEND;VALUE=DATE:20240711
DTSTAMP:20260415T155217
CREATED:20240125T172523Z
LAST-MODIFIED:20240125T172523Z
UID:3916-1720396800-1720655999@scge.mcw.edu
SUMMARY:The Global Cell & Gene Therapy Summit
DESCRIPTION:The International Summit on Cell and Gene Therapy serves as a platform to explore the fundamental concepts of these transformative therapies. The summit brings together experts from academia and industry to discuss a range of topics related to cell and gene therapy\, including ethical considerations\, social implications\, tools\, techniques\, marketing strategies\, and the commercialization of cell and gene therapy products. It also showcases the latest research progress in CGT and explores opportunities for further enhancements in availability and productivity of these therapies. \nBoston\, MA (Hybrid) \nhttps://cgtsummit.com/
URL:https://scge.mcw.edu/events/the-global-cell-gene-therapy-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112452.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240709
DTEND;VALUE=DATE:20240712
DTSTAMP:20260415T155217
CREATED:20240612T154313Z
LAST-MODIFIED:20240612T154313Z
UID:4280-1720483200-1720742399@scge.mcw.edu
SUMMARY:In Vivo Cell Engineering & Gene Editing Summit
DESCRIPTION:Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic. \nBoston\, MA
URL:https://scge.mcw.edu/events/in-vivo-cell-engineering-gene-editing-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104251.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240716
DTEND;VALUE=DATE:20240718
DTSTAMP:20260415T155217
CREATED:20240612T153359Z
LAST-MODIFIED:20240612T153359Z
UID:4274-1721088000-1721260799@scge.mcw.edu
SUMMARY:CMC Strategy Forum North America
DESCRIPTION:The CMC Strategy Forum has established an excellent reputation for being the premier scientific meeting that brings together regulatory\, industry\, and academic professionals to discuss key emerging CMC issues that affect biotechnology in an open and transparent workshop format. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product. \n\nGaithersburg\, MD
URL:https://scge.mcw.edu/events/cmc-strategy-forum-north-america-july/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103213.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240820
DTEND;VALUE=DATE:20240823
DTSTAMP:20260415T155217
CREATED:20240612T154617Z
LAST-MODIFIED:20240612T154617Z
UID:4283-1724112000-1724371199@scge.mcw.edu
SUMMARY:Next Generation Lipid-Based Nanoparticles Delivery Summit
DESCRIPTION:The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit is the only event dedicated entirely to lipid-based nanoparticle delivery\, where we bring together 120+ experts in LNP non-clinical\, delivery\, particle engineering\, and formulation from the likes of Teressa\, Sanofi\, MediciBio\, CureVac. Together\, we’re on a mission to revolutionize drug delivery\, conquering the intricate challenges of lipid-based nanoparticle delivery beyond RNAs and extending cargos to destinations beyond the liver. \nBoston\, MA \n 
URL:https://scge.mcw.edu/events/next-generation-lipid-based-nanoparticles-delivery-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104553.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240901
DTSTAMP:20260415T155217
CREATED:20240125T172918Z
LAST-MODIFIED:20240125T172939Z
UID:3919-1724716800-1725148799@scge.mcw.edu
SUMMARY:Genome Engineering: CRISPR Frontiers
DESCRIPTION:The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms\, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems. \nCold Spring Harbor\, NY \nhttps://meetings.cshl.edu/meetings.aspx?meet=crispr&year=24
URL:https://scge.mcw.edu/events/genome-engineering-crispr-frontiers-4/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112826.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240910
DTEND;VALUE=DATE:20240913
DTSTAMP:20260415T155217
CREATED:20240612T154901Z
LAST-MODIFIED:20240612T154901Z
UID:4286-1725926400-1726185599@scge.mcw.edu
SUMMARY:Gene Therapy for Ophthalmic Disorders Summit
DESCRIPTION:Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest developments in vector engineering to target retinal cells more effectively with higher transduction efficiency. Understand the crucial role of endpoint selection to clearly demonstrate product efficacy to the FDA & EMA. Understand the risk-benefit profiles of different ocular administration routes including intravitreal\, subretinal\, and suprachoroidal delivery to choose the best option for your specific indication. Learn from successful clinical trials as well as where trials have fallen short of expectations to take forward crucial lessons learnt on progressing a gene therapy rapidly through the clinic without compromising on safety. \nBoston\, MA
URL:https://scge.mcw.edu/events/gene-therapy-for-ophthalmic-disorders-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104844.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240910T100000
DTEND;TZID=America/Chicago:20240910T103000
DTSTAMP:20260415T155217
CREATED:20240820T163056Z
LAST-MODIFIED:20240820T163056Z
UID:4442-1725962400-1725964200@scge.mcw.edu
SUMMARY:Webinar: Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality
DESCRIPTION:This webinar will explore the utility of a Universal AAV Standard in assessing the quantity and genomic integrity of AAV vectors. The Universal AAV Standard combines multiple target sites for commonly used promoters\, poly(A) regions and functional CDS. Stacking of these elements in Universal AAV Standard allows it to serve as a single positive control for evaluating the performance of dPCR assays and assessing the quantity\, quality\, and genomic integrity of AAV genomes. \nRegister at https://www.workcast.com/register?cpak=5801990019211892&referrer=tw  \n 
URL:https://scge.mcw.edu/events/webinar-considerations-in-leveraging-the-universal-aav-standard-for-dpcr-to-assess-aav-genomes-quantity-and-quality/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112916.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240921
DTSTAMP:20260415T155217
CREATED:20240808T143712Z
LAST-MODIFIED:20240808T143712Z
UID:4358-1726704000-1726876799@scge.mcw.edu
SUMMARY:HI-POCT 2024
DESCRIPTION:IEEE-EMBS International Conference on Health Innovations in Point of Care Technology (IEEE HI-POCT) is the premier conference in the areas of Health innovations in point-of-care technologies. In its eighth year\, this IEEE EMB Strategic Conference will emphasize funding opportunities and the promise and pitfalls of the journey from idea to patient. The conference will provide a strategic forum in which clinicians\, industry experts\, innovation experts\, researchers\, and students will examine how to define unmet clinical needs and successfully travel along the innovation cycle toward commercialization and patient impact. Clinical\, technological\, regulatory\, and marketing aspects of this learnable process will be stressed. Expert panels will discuss learnings in the development\, translation\, and commercialization of technologies and challenges in bringing medical care innovation to community health. \nTuscon\, AZ \n\nHome \n\n 
URL:https://scge.mcw.edu/events/hi-poct-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-093624.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T073000
DTEND;TZID=America/Chicago:20240920T173000
DTSTAMP:20260415T155217
CREATED:20240710T134050Z
LAST-MODIFIED:20240710T134155Z
UID:4307-1726817400-1726853400@scge.mcw.edu
SUMMARY:The Safe and Effective Practice of AAV Gene Therapy
DESCRIPTION:Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium\, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. SCGE researchers Lindsey George\, Beverly Davidson\, and Rebecca Ahrens-Nicklas are scheduled to be speaking at the event. \nFriday September 20\, 2024 || Philadelphia\, PA \nView the registration info here
URL:https://scge.mcw.edu/events/the-safe-and-effective-practice-of-aav-gene-therapy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-10-083625.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T100000
DTEND;TZID=America/Chicago:20240920T153000
DTSTAMP:20260415T155217
CREATED:20240723T134352Z
LAST-MODIFIED:20240723T134352Z
UID:4333-1726826400-1726846200@scge.mcw.edu
SUMMARY:Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
DESCRIPTION:The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases. \nThe objectives of this listening meeting are to hear from patients and care partners on their perspectives on short-term and long-term risks of approved gene therapy products\, to learn what types of information patients would find helpful in their decision-making when considering gene therapy\, to learn about their considerations and experience with participating in long-term studies after receiving a gene therapy\, and to help inform patient-centered protocols for long-term studies that include gene therapy outcomes.  The meeting will be divided into two sessions. \nRegister for the Zoom meeting here: https://web.cvent.com/event/0b2da86e-f7d1-4288-9d11-2cb9cabe87c5/regProcessStep \nRegistration will close on Thursday\, September 19\, 2024\, at 11:59 pm ET. A recording and other relevant meeting materials will be posted online following the event.
URL:https://scge.mcw.edu/events/meeting-1-patient-and-care-partner-perspectives-on-safety-considerations-for-approved-gene-therapy-treatments-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-23-084318.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20260415T155217
CREATED:20240820T162113Z
LAST-MODIFIED:20240820T162211Z
UID:4435-1727049600-1727222399@scge.mcw.edu
SUMMARY:2024 Policy Summit
DESCRIPTION:The 2024 Policy Summit will include experts on topics such as global regulatory harmonization\, clinical development challenges\, the payment policy landscape\, CGT investment insights\, and more. Join other cell and gene therapy professionals at this 1.5-day event to learn about public policies and regulatory trends impacting the field. \nWashington DC/Hybrid \nRegister at https://www.asgct.org/advocacy/events-and-opportunities/policy-summit/registration \n 
URL:https://scge.mcw.edu/events/2024-policy-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/ASGCT-policy-summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240927
DTSTAMP:20260415T155217
CREATED:20240808T145035Z
LAST-MODIFIED:20240808T145035Z
UID:4365-1727136000-1727395199@scge.mcw.edu
SUMMARY:3rd Annual Lipid Nanoparticles Development Summit Europe
DESCRIPTION:The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery\, Characterisation\, Translatability\, Formulation\, Biodistribution\, Manufacturing and much more. These industry leaders are gathering in Berlin this September to bring the greatest challenges in LNP development to the fore\, tackling them head on to ensure 2024 is the year of the LNP. \nBerlin\, Germany \nLearn more at: https://lipid-nanoparticle-development-europe.com/ 
URL:https://scge.mcw.edu/events/3rd-annual-lipid-nanoparticles-development-summit-europe/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-095000.png
END:VEVENT
END:VCALENDAR